1. Mao, Yunzi, Zhang, Jiaojiao, Zhou, Qian, Xu, Wei, Zhao, Shimin. 2024. Hypoxia induces mitochondrial protein lactylation to limit oxidative phosphorylation. In Cell research, 34, 13-30. doi:10.1038/s41422-023-00864-6. https://pubmed.ncbi.nlm.nih.gov/38163844/
2. Liu, Jiaxin, Li, Yimin, Xiao, Qing, Yi, Hanxi, Yin, Gang. 2022. Identification of CPT2 as a prognostic biomarker by integrating the metabolism-associated gene signature in colorectal cancer. In BMC cancer, 22, 1038. doi:10.1186/s12885-022-10126-0. https://pubmed.ncbi.nlm.nih.gov/36195841/
3. Liu, Fuqiang, Li, Xiaoqing, Yan, Han, Wu, Fan, Jiang, Zheng. 2022. Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer. In Cellular signalling, 92, 110267. doi:10.1016/j.cellsig.2022.110267. https://pubmed.ncbi.nlm.nih.gov/35108639/
4. Megarbane, Andre, Bizzari, Sami, Deepthi, Asha, Delague, Valérie, Urtizberea, J Andoni. . A 20-year Clinical and Genetic Neuromuscular Cohort Analysis in Lebanon: An International Effort. In Journal of neuromuscular diseases, 9, 193-210. doi:10.3233/JND-210652. https://pubmed.ncbi.nlm.nih.gov/34602496/
5. Zeng, Kai, Li, Qinyu, Song, Guoda, Miao, Jianping, Liu, Bo. 2023. CPT2-mediated fatty acid oxidation inhibits tumorigenesis and enhances sorafenib sensitivity via the ROS/PPARγ/NF-κB pathway in clear cell renal cell carcinoma. In Cellular signalling, 110, 110838. doi:10.1016/j.cellsig.2023.110838. https://pubmed.ncbi.nlm.nih.gov/37541641/
智鼠故事 
